WEIYI PENG to Multicenter Studies as Topic
This is a "connection" page, showing publications WEIYI PENG has written about Multicenter Studies as Topic.
Connection Strength
0.033
-
The HGF/c-MET Pathway Is a Driver and Biomarker of VEGFR-inhibitor Resistance and Vascular Remodeling in Non-Small Cell Lung Cancer. Clin Cancer Res. 2017 Sep 15; 23(18):5489-5501.
Score: 0.033